We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Canada’s AI-healthcare company Imagia Cybernetics and cancer genomics company Canexia Health have combined their businesses to enhance access to precision oncology. The two companies have been working with
Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced that it has entered into a strategic agreement with Una Health (Una) for the UK distribution of the Veros Covid-19 Test, the first
Canada-based rapid vertical flow diagnostics provider MedMira has received the CE mark approval for its REVEALCovid-19 PLUS total antibody test. REVEALCovid-19 PLUS is designed to detect the presence
Rockley Photonics, a provider of photonics-based health monitoring solutions, has developed a Bioptx biomarker sensing platform for the medical and healthcare market. Bioptx sensing platform includes a wide
Cytovale™, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, has received additional funding from Biomedical Research
CroíValve, a medical device maker focused on tricuspid regurgitation treatment, has raised €8m in a Series A funding round to study its DUO coaptation valve system. Led by
Huma.AI has added a post-market surveillance (PMS) solution to its AI-based business intelligence platform for the healthcare industry. The PMS feature is specifically designed to help device and
Thermo Fisher Scientific Inc., today announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution
US-based laboratory testing company Labcorp has rolled out a new online platform that allows its customers to directly purchase the Labcorp OnDemand tests online. In addition to the
German molecular genetics diagnostic company Mainz Biomed has started its clinical study, ColoFuture, to evaluate the potential integration of novel mRNA biomarkers into ColoAlert. ColoAlert is a colorectal